164 related articles for article (PubMed ID: 15378690)
21. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
23. Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.
Miura N; Takemori N; Kikugawa T; Tanji N; Higashiyama S; Yokoyama M
Mol Oncol; 2012 Jun; 6(3):311-22. PubMed ID: 22265592
[TBL] [Abstract][Full Text] [Related]
24. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.
Sun Y; Zhai L; Ma S; Zhang C; Zhao L; Li N; Xu Y; Zhang T; Guo Z; Zhang H; Xu P; Zhao X
Cancer Lett; 2018 Apr; 418():97-108. PubMed ID: 29331417
[TBL] [Abstract][Full Text] [Related]
26. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
27. Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis.
Taoka Y; Matsumoto K; Ohashi K; Minamida S; Hagiwara M; Nagi S; Saito T; Kodera Y; Iwamura M
Biomed Res; 2015; 36(4):253-61. PubMed ID: 26299484
[TBL] [Abstract][Full Text] [Related]
28. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
29. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
30. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
31. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
[TBL] [Abstract][Full Text] [Related]
32. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
34. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
35. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation.
D'Aguanno S; D'Alessandro A; Pieroni L; Roveri A; Zaccarin M; Marzano V; De Canio M; Bernardini S; Federici G; Urbani A
J Proteome Res; 2011 Feb; 10(2):416-28. PubMed ID: 21128686
[TBL] [Abstract][Full Text] [Related]
36. A systems biology case study of ovarian cancer drug resistance.
Chen JY; Shen C; Yan Z; Brown DP; Wang M
Comput Syst Bioinformatics Conf; 2006; ():389-98. PubMed ID: 17369659
[TBL] [Abstract][Full Text] [Related]
37. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
[TBL] [Abstract][Full Text] [Related]
38. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
Chen J; Adikari M; Pallai R; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2008 May; 61(6):979-87. PubMed ID: 17661040
[TBL] [Abstract][Full Text] [Related]
39. Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
Sørensen BS; Horsman MR; Vorum H; Honoré B; Overgaard J; Alsner J
Radiother Oncol; 2009 Sep; 92(3):443-9. PubMed ID: 19541378
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]